Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3014591	s-leppäe	u/ml (—)	127	127	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Vasomotor and allergic rhinitis

8.57

25.77

1.0

—

Allergic rhinitis

6.99

20.48

1.0

—

Pollen allergy

7.51

17.57

1.0

—

Asthma (mode)

4.60

10.76

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

6.21

10.72

1.0

—

Conjunctivitis

3.59

10.54

1.0

—

Disorders of conjunctiva

3.55

10.54

1.0

—

Asthma, excluding more controls

4.70

10.52

1.0

—

Examination and observation for other reasons

4.79

9.86

1.0

—

Asthma

4.35

9.72

1.0

—

Asthma (only as main-diagnosis), excluding more controls

4.21

7.86

1.0

—

Allergic conjunctivitis

3.37

7.70

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3.51

7.60

1.0

—

Asthma (only as main-diagnosis)

3.91

7.26

1.0

—

Asthma, including avohilmo

2.77

7.18

1.0

—

Asthma, unspecified (mode), excluding more controls

4.77

7.12

1.0

—

Chronic sinusitis

4.44

6.69

1.0

—

Asthma, unspecified (mode)

4.35

6.45

1.0

—

Other diseases of upper respiratory tract

2.92

6.29

1.0

—

Asthma (diagnoses ohter than nonallergic)

2.82

6.24

1.0

—

Exposure to other specified factors

2.94

6.19

1.0

—

Medical observation and evaluation for suspected diseases and conditions

3.57

5.86

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.53

5.74

1.0

—

Neurotic, stress-related and somatoform disorders

2.69

5.67

1.0

—

Anxiety disorders

2.65

5.51

1.0

—

3.37

5.49

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.87

5.25

1.0

—

Recurrent or chronic depression

3.52

5.09

1.0

—

Asthma, hospital admission 2, infections

3.07

5.02

1.0

—

Asthma-related infections

3.07

5.02

1.0

—

Unspecified fall

3.25

4.94

1.0

—

All anxiety disorders

2.80

4.91

1.0

—

Injuries to the neck

4.29

4.82

1.0

—

Transport accidents

3.35

4.76

1.0

—

Anxiety (asthma-related co-morbidities)

2.70

4.60

1.0

—

Anxiety disorders, excluding more controls

2.51

4.47

1.0

—

Dental caries 2 and operation codes

2.49

4.46

1.0

—

Disturbances of skin sensation

3.72

4.36

1.0

—

Dermatitis and eczema

2.28

4.19

1.0

—

Abnormalities of breathing

2.38

4.19

1.0

—

Diseases of the respiratory system

3.17

4.14

1.0

—

Acute sinusitis

2.77

3.98

1.0

—

Adverse effects, not elsewhere classified

3.93

3.97

1.0

—

Other pulmonary diagnosis

2.84

3.88

1.0

—

Excluding asthma or asthma-COPD overlap

2.84

3.88

1.0

—

COPD differential diagnosis

2.84

3.88

1.0

—

ILD differential diagnosis

2.84

3.88

1.0

—

Female infertility, cervigal, vaginal, other or unspecified origin

3.47

3.83

1.0

—

Temporomandibular joint disorders, including avohilmo

2.77

3.83

1.0

—

Depression

2.24

3.74

1.0

—

Dental caries 2

2.32

3.73

1.0

—

Voice disturbances

4.00

3.69

1.0

—

Vocal cord dysfunction

6.76

3.65

1.0

—

Other and unspecified effects of external causes

3.11

3.64

1.0

—

Malaise and fatigue

2.90

3.56

1.0

—

Injuries to the ankle and foot

2.33

3.44

1.0

—

Other anxiety disorders

2.62

3.40

1.0

—

Speech therapy

3.71

3.35

1.0

—

Dental caries 2, only avohilmo

2.24

3.34

1.0

—

Non-allergic asthma (mode), excluding more controls

5.66

3.31

1.0

—

Unspecified acute lower respiratory infection

5.34

3.19

1.0

—

Conjunctivitis (acute, non atopic)

3.32

3.17

1.0

—

Dental operations, only avohilmo

2.93

3.16

1.0

—

Asthma, hospital admissions , main diagnosis only

2.19

3.15

1.0

—

Dental caries, including avohilmo

2.56

3.14

1.0

—

Dental caries 1

2.56

3.14

1.0

—

Diseases of middle ear and mastoid

2.37

3.08

1.0

—

Superficial injury of wrist and hand

3.45

3.04

1.0

—

Sleep disorders (combined)

2.22

3.02

1.0

—

Other menopausal disorders

3.84

2.97

1.0

—

Allergic asthma (mode), excluding more controls

4.21

2.94

1.0

—

Selective serotonin reuptake inhibitors

2.12

2.92

1.0

—

Non-allergic asthma (mode)

4.66

2.89

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

4.10

2.88

1.0

—

Chronic lower respiratory diseases

1.94

2.87

1.0

—

Disorders of eyelid, lacrimal system and orbit

2.27

2.80

1.0

—

Somatoform disorder

4.45

2.79

1.0

—

Dental caries 1 and operation codes

2.39

2.78

1.0

—

Persons encountering health services for examination and investigation

2.58

2.73

1.0

—

Dental operations

2.87

2.71

1.0

—

Mood disorders, excluding more controls

2.08

2.71

1.0

—

Fibromyalgia

6.01

2.70

1.0

—

Sciatica+with lumbago

2.61

2.69

1.0

—

Mood [affective] disorders

2.00

2.67

1.0

—

Pain in joint

2.61

2.67

1.0

—

Mood disorders

1.99

2.66

1.0

—

Symptoms and signs involving speech and voice

3.13

2.64

1.0

—

Allergic asthma (mode)

3.68

2.62

1.0

—

Urticaria and erythema

2.65

2.61

1.0

—

Dental caries 1, only avohilmo

2.37

2.61

1.0

—

Dermatitis

2.46

2.61

1.0

—

Depression medications

2.70

2.60

1.0

—

Bronchitis

1.97

2.58

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2.90

2.58

1.0

—

Other antidepressants

2.07

2.57

1.0

—

Other and unspecified urticaria

3.60

2.57

1.0

—

Asthma and allergy, excluding more controls

4.61

2.56

1.0

—

Depression or dysthymia

2.31

2.55

1.0

—

KRA_PSY_EATING, excluding more controls

5.44

2.53

1.0

—

Acute upper respiratory infections

1.99

2.52

1.0

—

Sleep apnoea

2.19

2.51

1.0

—

Exposure to unspecified factor

1.96

2.46

1.0

—

Asthma and allergy

4.32

2.44

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.45

2.43

1.0

—

Sleep apnoea, including avohilmo

2.07

2.40

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

5.00

2.40

1.0

—

Diseases of the musculoskeletal system and connective tissue

2.27

2.40

1.0

—

Headache

2.15

2.39

1.0

—

Other soft tissue disorders, not elsewhere classified

2.00

2.39

1.0

—

Dermatographic urticaria

6.26

2.37

1.0

—

Urticaria

2.75

2.37

1.0

—

Other acute lower respiratory infections

2.35

2.36

1.0

—

Long labour

2.91

2.30

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.14

2.21

1.0

—

Hypothyroidism, strict autoimmune

2.07

2.21

1.0

—

Undetermined asthma, excluding more controls

5.55

2.21

1.0

—

Dyspnoea

2.04

2.21

1.0

—

Other disorders of lacrimal gland

2.78

2.20

1.0

—

Injuries to the hip and thigh

2.65

2.18

1.0

—

Irritable bowel syndrome

2.62

2.18

1.0

—

Dental pulpitis 2

2.34

2.18

1.0

—

Dental caries 3

2.16

2.18

1.0

—

Atopic dermatitis

2.05

2.17

1.0

—

Psychiatric diseases

1.85

2.14

1.0

—

Diseases of the skin and subcutaneous tissue

1.89

2.13

1.0

—

Other headache syndromes

2.45

2.10

1.0

—

Disorders of lacrimal system

2.56

2.09

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.00

2.09

1.0

—

Injury of muscle and tendon at hip and thigh level

5.00

2.07

1.0

—

Other complications of surgical and medical care, not elsewhere classified

5.00

2.07

1.0

—

Dental pulpitis 2, only avohilmo

2.27

2.06

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.96

2.05

1.0

—

Acute suppurative otitis media

2.44

2.05

1.0

—

Postmenopausal bleeding

3.85

2.02

1.0

—

Other and unspecified dermatitis

2.40

2.02

1.0

—

Covid-19 suspected case

2.81

2.00

1.0

—

Internal derangement of knee

2.63

1.99

1.0

—

Asthma/COPD (KELA code 203)

1.84

1.98

1.0

—

Diseases of the ear and mastoid process

1.77

1.97

1.0

—

Obesity related asthma

2.96

1.93

1.0

—

Phobic anxiety disorders

3.75

1.93

1.0

—

Extrapyramidal and movement disorders

2.73

1.93

1.0

—

Female infertility

2.47

1.93

1.0

—

Keratitis

2.57

1.92

1.0

—

1.81

1.91

1.0

—

Episodal and paroxysmal disorders

1.75

1.91

1.0

—

Nerve, nerve root and plexus disorders

1.85

1.90

1.0

—

Infections of the skin and subcutaneous tissue

2.10

1.89

1.0

—

Genitourinary diseases

2.03

1.89

1.0

—

Generalized anxiety disorder

3.18

1.88

1.0

—

Dental caries 2 and operation codes, only avohilmo

1.87

1.0

—

Migraine without aura

2.65

1.86

1.0

—

Endometriosis of pelvic peritoneum

3.14

1.85

1.0

—

Other viral diseases

2.39

1.84

1.0

—

Other keratitis

3.53

1.83

1.0

—

Undetermined asthma

4.17

1.82

1.0

—

Any mental disorder

1.76

1.81

1.0

—

Gastro-oesophageal reflux disease

2.14

1.81

1.0

—

Intestinal infectious diseases

100

1.79

1.80

1.0

—

Otitis externa

2.76

1.79

1.0

—

Diseases of the eye and adnexa

1.87

1.78

1.0

—

Gastrointestinal diseases

1.93

1.76

1.0

—

Dental caries 3, only avohilmo

2.00

1.76

1.0

—

Injuries to the wrist and hand

1.76

1.75

1.0

—

Other specific joint derangements/joint disorders

1.86

1.72

1.0

—

Endometriosis ASRM stages 1,2

2.92

1.72

1.0

—

Adenomyosis (Endometriosis of uterus)

3.85

1.71

1.0

—

Temporomandibular joint disorders

3.85

1.71

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.52

1.70

1.0

—

Endometriosis

2.42

1.70

1.0

—

Abdominal and pelvic pain

1.81

1.70

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

2.29

1.70

1.0

—

Falls/tendency to fall

1.69

1.67

1.0

—

Soft tissue disorders related to use, overuse and pressure

2.80

1.65

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.72

1.63

1.0

—

Fall on same level

1.66

1.63

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.32

1.62

1.0

—

Otitis externa, unspecified

3.57

1.61

1.0

—

Symptoms and signs involving the digestive system and abdomen

1.77

1.61

1.0

—

Cough

2.34

1.61

1.0

—

Finngen Rheumatological endpoints

1.75

1.59

1.0

—

Asthma-related pneumonia

2.50

1.59

1.0

—

Asthma, hospital admissions 3, pneumonia

2.50

1.59

1.0

—

Asthma-related pneumonia or sepsis

2.50

1.59

1.0

—

Chronic diseases of tonsils and adenoids

1.92

1.59

1.0

—

Insomnia

3.00

1.58

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

3.00

1.58

1.0

—

Nonorganic sleeping disorders, excluding more controls

3.00

1.58

1.0

—

Eating disorders

3.00

1.58

1.0

—

Eating disorder

3.00

1.58

1.0

—

Diseases of oesophagus, stomach and duodenum

1.72

1.55

1.0

—

Hypothyroidism, other/unspecified

1.75

1.52

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.75

1.52

1.0

—

Restless leg syndrome

3.34

1.52

1.0

—

FESS (DNB20)

3.34

1.52

1.0

—

Ethmoidectomy

3.34

1.52

1.0

—

Soft tissue disorders

1.69

1.51

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2.59

1.51

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.26

1.50

1.0

—

Panic disorder

2.86

1.50

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.66

1.47

1.0

—

Infections, IBD-co-morbidities

3.31

1.45

1.0

—

Other enthesopathies

2.50

1.45

1.0

—

Other extrapyramidal and movement disorders in other diseases

2.73

1.43

1.0

—

Enthesopathies of lower limb, excluding foot

2.73

1.43

1.0

—

Inguinal hernia

2.18

1.43

1.0

—

Special screening examination for infectious and parasitic diseases

2.49

1.40

1.0

—

Codes for special purposes

2.00

1.37

1.0

—

Provisional assignment of new diseases of uncertain etiology

2.00

1.37

1.0

—

Oral corticosteroids

1.66

1.37

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.78

1.37

1.0

—

Convulsions, not elsewhere classified

0.00

1.34

0.0

1.0

—

Fenamates

3.07

1.34

1.0

—

Care involving use of rehabilitation procedures

1.87

1.34

1.0

—

Continuous positive airway pressure

2.59

1.33

1.0

—

Medicines for HER+ breast cancer

0.00

1.31

0.0

1.0

—

Childhood allergy (age < 16)

2.12

1.30

1.0

—

Car occupant injured in other and unspecified transport accidents

2.50

1.30

1.0

—

Systemic connective tissue disorders

2.35

1.29

1.0

—

Accidents

1.77

1.29

1.0

—

Superficial injury of ankle and foot

2.78

1.28

1.0

—

Inflammatory disease of uterus

2.78

1.28

1.0

—

Superficial injury of abdomen, lower back and pelvis

2.78

1.28

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

2.78

1.28

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.95

1.28

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.00

1.27

1.0

—

Disorders of sclera, cornea, iris and ciliary body

1.94

1.27

1.0

—

Diseases of external ear

2.29

1.26

1.0

—

Pain (limb, back, neck, head abdominally)

1.82

1.25

1.0

—

Dental caries 3 and operation codes

1.78

1.25

1.0

—

Migraine without aura and triptan purchases

2.40

1.24

1.0

—

Myalgia

2.40

1.24

1.0

—

Other nutritional deficiencies

1.77

1.22

1.0

—

Persistent mood disorders

2.63

1.21

1.0

—

Other gastritis (incl. Duodenitis)

2.63

1.21

1.0

—

Hypertrophy of breast in women and men

2.63

1.21

1.0

—

Fracture of lumbar spine and pelvis

2.63

1.21

1.0

—

Hernia

1.70

1.21

1.0

—

Nonsuppurative otitis media

2.06

1.21

1.0

—

Any gastric operation

1.60

1.19

1.0

—

GASTRO-related operations

1.60

1.19

1.0

—

Other diseases of hard tissues of teeth

1.86

1.19

1.0

—

Noninflammatory disorders of female genital tract

1.92

1.19

1.0

—

Rotator cuff syndrome

2.06

1.18

1.0

—

Emergency coronary revascularization (for ACS)

0.00

1.18

0.0

1.0

—

Pure hypercholesterolaemia

1.99

1.18

1.0

—

Obesity and other hyperalimentation

1.78

1.17

1.0

—

1.65

1.16

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.65

1.16

1.0

—

L02BG Aromatase inhibitors

0.00

1.16

0.0

1.0

—

Disorders of vitreous body and globe

2.05

1.15

1.0

—

Use of hypnotics and sedatives

1.59

1.15

1.0

—

Low back pain

1.71

1.14

1.0

—

Suicide or other Intentional self-harm

0.00

1.14

0.0

1.0

—

Malignant neoplasm of breast, HER-positive

0.00

1.13

0.0

1.0

—

Fever of other and unknown origin

1.85

1.13

1.0

—

Cutaneous abscess, furuncle and carbuncle

2.33

1.12

1.0

—

Lower back pain or/and sciatica

1.58

1.12

1.0

—

Carpal tunnel syndrome

1.91

1.12

1.0

—

Other joint disorders

1.58

1.11

1.0

—

Factors influencing health status and contact with health services

2.34

1.11

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.54

1.10

1.0

—

Other disorders of patella

2.38

1.09

1.0

—

Certain infectious and parasitic diseases

1.56

1.08

1.0

—

Non-selective monoamine reuptake inhibitors

2.19

1.08

1.0

—

Other/unspecified dorsalgia

1.94

1.08

1.0

—

Deforming dorsopathies

2.12

1.05

1.0

—

Other viral diseases, not elsewhere classified

2.12

1.05

1.0

—

Delivery

1.81

1.03

1.0

—

Acute bronchitis

1.96

1.03

1.0

—

Blepharochalasis

2.27

1.03

1.0

—

Other medical care

2.07

1.03

1.0

—

Opioids

1.53

1.02

1.0

—

ILD medications

1.49

1.01

1.0

—

Disorders of synovium and tendon

1.83

1.01

1.0

—

Other arrhythmias

1.75

1.00

1.0

—

Codeine or tramadol medication

1.52

1.00

1.0

—

Other maternal disorders predominantly related to pregnancy

1.68

1.00

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.86

0.99

1.0

—

Dorsalgia

1.53

0.99

1.0

—

Parasetamol

1.59

0.99

1.0

—

Persons encountering health services for specific procedures and health care

1.50

0.98

1.0

—

COPD/asthma/ILD related infections

1.53

0.98

1.0

—

COPD/asthma related infections

1.53

0.98

1.0

—

Cervicalgia

2.17

0.98

1.0

—

Pain in limb

1.63

0.98

1.0

—

Disorders of vitreous body

1.96

0.97

1.0

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

0.00

0.97

0.0

1.0

—

Focal epilepsy, strict definition

0.00

0.96

0.0

1.0

—

Focal epilepsy

0.00

0.96

0.0

1.0

—

Embedded and impacted teeth

1.85

0.93

1.0

—

Other retinal disorders

1.76

0.93

1.0

—

Other disorders of eyelid

2.23

0.93

1.0

—

Codeine

1.52

0.93

1.0

—

Benzodiazepine use

1.54

0.93

1.0

—

Obesity

1.67

0.92

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.53

0.92

1.0

—

Sleep disorders

2.14

0.91

1.0

—

Triptan medication for migraine, single purchase ok

1.53

0.91

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.53

0.91

1.0

—

Varicose veins

1.95

0.90

1.0

—

Obesity due to excess calories

1.75

0.90

1.0

—

Injury, poisoning and certain other consequences of external causes

1.77

0.89

1.0

—

Dental pulpitis 1

1.48

0.89

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.47

0.89

1.0

—

Dental pulpitis 4

1.47

0.89

1.0

—

Nonorganic sleeping disorders

2.07

0.89

1.0

—

Supervision of normal pregnancy

1.91

0.88

1.0

—

Obesity, other/unspecified

1.91

0.88

1.0

—

Mouth breathing

1.90

0.88

1.0

—

Maternal care for other conditions predominantly related to pregnancy

2.04

0.88

1.0

—

Medical abortion

0.52

0.87

1.0

—

Impacted teeth

1.86

0.87

1.0

—

Diaphragmatic hernia

2.00

0.87

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.72

0.86

1.0

—

Cardiac arrhythmias

1.60

0.85

1.0

—

Venous thromboembolism

1.81

0.85

1.0

—

Single spontaneous delivery

1.73

0.85

1.0

—

First line medication for Crohn's disease

1.44

0.84

1.0

—

Pedal cyclist injured in transport accident

1.94

0.84

1.0

—

Antenatal screening

1.80

0.84

1.0

—

Other and unspecified disorders of vitreous body

1.93

0.84

1.0

—

Suppurative and unspecified otitis media

1.71

0.83

1.0

—

Excessive attrition of teeth

1.76

0.82

1.0

—

Complications of procedures, not elsewhere classified

1.56

0.82

1.0

—

Striking against or struck by other objects

1.74

0.82

1.0

—

External causes of morbidity and mortality

1.63

0.81

1.0

—

Other arthritis (FG)

1.88

0.81

1.0

—

Diseases of pulp and periapical tissues

1.88

0.81

1.0

—

Metabolic disorders

1.53

0.81

1.0

—

Other external causes of accidental injury

1.57

0.81

1.0

—

Triptan medication for migraine, min. 3 purchases

1.56

0.80

1.0

—

Diseases of inner ear

1.70

0.80

1.0

—

Injuries to the shoulder and upper arm

1.55

0.80

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.00

0.80

0.0

1.0

—

Neurological diseases

1.48

0.80

1.0

—

Neurological diseases, wide definition

1.81

0.79

1.0

—

Poor fetal growth

0.00

0.79

0.0

1.0

—

Diagnoses used for exclusion with ILD

0.00

0.79

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.82

0.79

1.0

—

Coronary revascularization (ANGIO or CABG)

0.00

0.78

0.0

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.78

0.0

1.0

—

Gestational diabetes (for exclusion)

1.69

0.78

1.0

—

Irregular menses

1.60

0.77

1.0

—

Meniscus derangement

1.76

0.77

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.77

0.0

1.0

—

ILD medications: immunosuppressive drugs

1.62

0.77

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.53

0.77

1.0

—

General symptoms and signs

1.42

0.77

1.0

—

Pain in throat and chest

1.53

0.77

1.0

—

Influenza and pneumonia

102

1.42

0.76

1.0

—

Other disorders of veins

1.76

0.76

1.0

—

Sequelae of external causes of morbidity and mortality

0.00

0.76

0.0

1.0

—

DVT of lower extremities and pulmonary embolism

1.76

0.76

1.0

—

Migraine

1.58

0.75

1.0

—

Inflammatory diseases of female pelvic organs

1.53

0.75

1.0

—

Persons encountering health services in other circumstances, wide

1.40

0.74

1.0

—

Ganglion

2.08

0.74

1.0

—

Dizziness and giddiness

1.57

0.74

1.0

—

Other systemic involvement of connective tissue (FG)

1.99

0.72

1.0

—

Dentofacial anomalies [including malocclusion]

1.78

0.72

1.0

—

L04AA Selective immunosuppressants

1.92

0.70

1.0

—

Intestinal stricture

1.92

0.70

1.0

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1.92

0.70

1.0

—

Oedema, not elsewhere classified

1.91

0.70

1.0

—

Anaemias

1.72

0.70

1.0

—

Acute pharyngitis

1.91

0.70

1.0

—

Spondylosis

1.72

0.70

1.0

—

Disorders of refraction and accommodation

1.70

0.69

1.0

—

Polycystic ovarian syndrome, consortium definition

1.46

0.69

1.0

—

Fissure and fistula of anal and rectal regions

1.85

0.68

1.0

—

Other systemic involvement of connective tissue

1.85

0.68

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

1.85

0.68

1.0

—

Gonarthrosis

1.69

0.68

1.0

—

Other obstetric conditions, not elsewhere classified

1.62

0.68

1.0

—

Arthropathies

1.41

0.68

1.0

—

Diabetes mellitus in pregnancy

1.66

0.67

1.0

—

Benign paroxysmal vertigo

1.79

0.66

1.0

—

Colonic or urogenital fistula

1.79

0.66

1.0

—

Functional dyspepsia

1.79

0.66

1.0

—

Other specified/unspecified arthritis

1.79

0.66

1.0

—

Dental pulpitis 1, only avohilmo

1.38

0.66

1.0

—

Dental pulpitis 4, only avohilmo

1.38

0.66

1.0

—

Maternal care for known or suspected abnormality of pelvic organs

1.61

0.65

1.0

—

Other diseases of intestines

1.37

0.65

1.0

—

Disorders of the thyroid gland

1.42

0.64

1.0

—

Coxibs

1.77

0.64

1.0

—

Atrial fibrillation and flutter with reimbursement

0.00

0.62

0.0

1.0

—

Diseases of male genital organs

1.62

0.62

1.0

—

Insulin, intermediate and long-acting

1.63

0.62

1.0

—

Ovarian cyst

1.60

0.61

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.67

0.61

1.0

—

Coronary angioplasty

0.00

0.61

0.0

1.0

—

Other degenerative diseases of the nervous system

0.00

0.61

0.0

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.61

0.0

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.58

0.60

1.0

—

Type 1 diabetes, strict definition

0.00

0.60

0.0

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.60

0.0

1.0

—

Glomerular diseases

0.00

0.60

0.0

1.0

—

All pneumoniae

101

1.37

0.60

1.0

—

Other disorders of skin and subcutaneous tissue

1.58

0.60

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

0.00

0.59

0.0

1.0

—

Schizophrenia

0.00

0.59

0.0

1.0

—

Peripheral artery disease

0.00

0.59

0.0

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

1.61

0.59

1.0

—

Other neurological diseases

1.58

0.58

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.51

0.58

1.0

—

Anomalies of dental arch relationship, including avohilmo

1.74

0.58

1.0

—

Haemorrhage from respiratory passages

0.00

0.58

0.0

1.0

—

Abnormalities of heart beat

1.70

0.57

1.0

—

Spinal stenosis

1.68

0.57

1.0

—

Superficial injury of lower leg

1.67

0.56

1.0

—

Type 1 diabetes

1.66

0.56

1.0

—

Other intervertebral disc disorders

1.45

0.56

1.0

—

Excessive, frequent and irregular menstruation

1.52

0.55

1.0

—

Hernia of abdominal wall

1.58

0.54

1.0

—

Iron deficiency anaemia

1.56

0.53

1.0

—

Ischaemic heart disease, wide definition

1.44

0.53

1.0

—

Haemorrhage in early pregnancy

1.54

0.53

1.0

—

Injuries to the thorax

1.54

0.53

1.0

—

Benign neoplasms

0.69

0.52

1.0

—

Insulin, fast-acting or short human

1.50

0.51

1.0

—

Insulin, fast-acting

1.50

0.51

1.0

—

Constipation

1.41

0.51

1.0

—

Shoulder lesions

1.53

0.50

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

1.33

0.50

1.0

—

Pregnancy with abortive outcome

0.65

0.48

1.0

—

Nutritional anaemias

1.48

0.47

1.0

—

Disorders of skin appendages

1.47

0.46

1.0

—

Diseases of oral cavity, salivary glands and jaws

1.37

0.46

1.0

—

Benign neoplasms

0.70

0.45

1.0

—

Concussion

1.47

0.45

1.0

—

Tonsillectomy and adenotomy

1.36

0.45

1.0

—

Acetic acid derivatives and related substances

1.74

0.45

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

0.69

0.45

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.48

0.44

1.0

—

Postpartum care and examination

1.68

0.44

1.0

—

Other disorders of ear

1.35

0.44

1.0

—

Pregnancy examination and test

1.64

0.44

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.61

0.43

1.0

—

Glucosamine medication

1.60

0.43

1.0

—

Atopic dermatitis, strict definition

1.43

0.42

1.0

—

Personality disorders, excluding more controls

1.56

0.42

1.0

—

Alzheimer disease, including avohilmo

0.00

0.42

0.0

1.0

—

Gingivitis and periodontal diseases

1.36

0.42

1.0

—

N06DA Anticholinesterases

0.00

0.41

0.0

1.0

—

Use of anticholinesterases

0.00

0.41

0.0

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.41

0.0

1.0

—

Degenerative diseases of the nervous system

0.00

0.41

0.0

1.0

—

Recurrent dislocation and subluxation of joint

0.00

0.41

0.0

1.0

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.41

0.0

1.0

—

Deep endometriosis

0.00

0.41

0.0

1.0

—

Cerebral palsy and other paralytic syndromes

0.00

0.41

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.41

0.0

1.0

—

Gout, FINNGEN

0.00

0.41

0.0

1.0

—

Agranulocytosis

0.00

0.41

0.0

1.0

—

Acute and transient psychotic disorders

0.00

0.41

0.0

1.0

—

Methotrexate

0.00

0.41

0.0

1.0

—

Other skin changes

0.00

0.41

0.0

1.0

—

L02BA Anti-estrogens

0.00

0.41

0.0

1.0

—

Other symptoms and signs involving the digestive system and abdomen

0.00

0.41

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

0.41

0.0

1.0

—

Cardiac murmurs and other cardiac sounds

0.00

0.41

0.0

1.0

—

Operations 2 for CAVS

0.00

0.41

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.41

0.0

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.41

0.0

1.0

—

Unspecific neurodegenerative disorder

0.00

0.40

0.0

1.0

—

Family history of malignant neoplasm

0.00

0.40

0.0

1.0

—

Foreign body on external eye

0.00

0.40

0.0

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

0.40

0.0

1.0

—

Aneurysms, operations, SAH

0.00

0.40

0.0

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

0.40

0.0

1.0

—

Gastroduodenal ulcer

0.00

0.40

0.0

1.0

—

Transient ischemic attack

1.48

0.40

1.0

—

Calcific aortic valvular stenosis, operated

0.00

0.40

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

0.40

0.0

1.0

—

Unspecified haematuria

1.48

0.40

1.0

—

Outcome of delivery

1.47

0.40

1.0

—

Specific personality disorders

1.47

0.40

1.0

—

Visual disturbances

1.33

0.40

1.0

—

Tooth eruption problems

1.46

0.40

1.0

—

Thyroiditis, ILD-related definition

0.00

0.40

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

0.40

0.0

1.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

0.40

0.0

1.0

—

Complications of labour and delivery

1.35

0.40

1.0

—

In situ neoplasms

1.45

0.39

1.0

—

Persons encountering health services in circumstances related to reproduction

1.36

0.39

1.0

—

Pacemaker

0.00

0.39

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.39

0.0

1.0

—

Lichen planus, including avohilmo

0.00

0.39

0.0

1.0

—

Sequelae with surgical and medical care as external cause

0.00

0.39

0.0

1.0

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.39

0.0

1.0

—

Atrial fibrillation and flutter

1.42

0.39

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

0.39

0.0

1.0

—

Injuries to the knee and lower leg

101

1.25

0.38

1.0

—

Disorders of breast

1.40

0.38

1.0

—

Acute tubulo-interstitial nephritis

1.35

0.38

1.0

—

In situ neoplasms

1.39

0.38

1.0

—

Other noninfective gastroenteritis and colitis

1.39

0.38

1.0

—

Other dorsopathies, not elsewhere classified

1.27

0.37

1.0

—

Lumbar disc prolapse

1.30

0.37

1.0

—

Appendectomy

1.34

0.37

1.0

—

Single delivery by caesarean section

1.45

0.36

1.0

—

L04AX Other immunosuppressants

1.27

0.36

1.0

—

Endocrine, nutritional and metabolic diseases

1.27

0.36

1.0

—

Other arthrosis

1.43

0.36

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.26

0.35

1.0

—

Complications of medical and surgical care

1.36

0.35

1.0

—

Tramadol

1.33

0.35

1.0

—

Dental caries 1 and operation codes, only avohilmo

1.37

0.35

1.0

—

Disorders of vestibular function (Vertigo)

1.39

0.35

1.0

—

Dorsopathies

1.24

0.34

1.0

—

Viral and other specified intestinal infections

1.36

0.34

1.0

—

Angina pectoris

1.35

0.34

1.0

—

Autoimmune diseases

1.23

0.33

1.0

—

Inflammatory bowel disease treatment related agents

1.23

0.33

1.0

—

Disorders of choroid and retina

1.37

0.33

1.0

—

Pneumonia, organism unspecified

1.28

0.33

1.0

—

Artrosis, including avohilmo

0.69

0.32

1.0

—

Spondylopathies

1.34

0.31

1.0

—

Other reaction to severe stress, and adjustment disorders

1.32

0.30

1.0

—

Other and unspecified tonsillitis

1.29

0.30

1.0

—

Parodontitis or/and operation codes

0.72

0.30

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.23

0.29

1.0

—

Sensorineural hearing loss

1.27

0.28

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

103

0.79

0.28

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.27

0.27

1.0

—

Other heart diseases, wide

1.23

0.27

1.0

—

Visual disturbances and blindness

1.27

0.27

1.0

—

Autoimmune diseases related-to ILD

104

0.76

0.27

1.0

—

Leiomyoma of uterus

0.65

0.27

1.0

—

Hard cardiovascular diseases

0.67

0.26

1.0

—

Fall on same level involving ice and snow

1.21

0.26

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.22

0.26

1.0

—

Gonarthrosis,primary

1.31

0.25

1.0

—

Second line medication for Crohn's disease

1.22

0.25

1.0

—

Other heart diseases

0.73

0.24

1.0

—

Implicit Sepsis

0.72

0.24

1.0

—

Bacterial Sepsis

1.35

0.23

1.0

—

Fracture at wrist and hand level

1.31

0.23

1.0

—

Menorrhagia

1.26

0.23

1.0

—

Explicit Sepsis

1.26

0.22

1.0

—

Sub-endpoint used in defining T1D endpoints

1.23

0.22

1.0

—

Personality disorders

1.22

0.22

1.0

—

Rheumatoid arthritis, including avohilmo

1.22

0.22

1.0

—

Coronary artery bypass grafting

0.00

0.22

0.0

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Use of other anti-dementia drugs

0.00

0.21

0.0

1.0

—

Use of memantine

0.00

0.21

0.0

1.0

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.00

0.21

0.0

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.21

0.0

1.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

0.00

0.21

0.0

1.0

—

Infections of breast associated with childbirth

0.00

0.21

0.0

1.0

—

Placenta praevia

0.00

0.21

0.0

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.21

0.0

1.0

—

Failed induction of labour

0.00

0.21

0.0

1.0

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.21

0.0

1.0

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.21

0.0

1.0

—

Viral hepatitis

0.00

0.21

0.0

1.0

—

MS-disease / Multiple Sclerosis

0.00

0.21

0.0

1.0

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.0

—

Heterophoria

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to tobacco

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.0

—

Ulcerative rectosigmoiditis

0.00

0.21

0.0

1.0

—

Mental disorders, not otherwise specified

0.00

0.21

0.0

1.0

—

Stomatitis and related lesions

0.00

0.21

0.0

1.0

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.21

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

0.21

0.0

1.0

—

Benign neoplasm of meninges

0.00

0.21

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

0.21

0.0

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.21

0.0

1.0

—

Rash and other nonspecific skin eruption

0.00

0.21

0.0

1.0

—

Diseases of peritoneum

0.00

0.21

0.0

1.0

—

Benign neoplasm of mouth and pharynx

0.00

0.21

0.0

1.0

—

Abnormalities of forces of labour

0.00

0.21

0.0

1.0

—

Abnormalities of gait and mobility

0.00

0.21

0.0

1.0

—

Secondary hypertension

0.00

0.21

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

0.21

0.0

1.0

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Gastric ulcer

0.00

0.21

0.0

1.0

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.21

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Gout, idiopatic and unspecified

0.00

0.21

0.0

1.0

—

Hyperplasia of prostate

0.00

0.21

0.0

1.0

—

0.00

0.21

0.0

1.0

—

Polycystic ovarian syndrome

0.00

0.21

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

0.21

0.0

1.0

—

Demyelinating diseases of the central nervous system

0.00

0.21

0.0

1.0

—

Disorders of optic nerve and visual pathways

0.00

0.21

0.0

1.0

—

Benign neoplasm of mouth and pharynx

0.00

0.21

0.0

1.0

—

Hypokalaemia

0.00

0.21

0.0

1.0

—

Diseases of the myoneural junction and muscle

0.00

0.21

0.0

1.0

—

Malignant melanoma

0.00

0.21

0.0

1.0

—

Hallux rigidus

0.00

0.21

0.0

1.0

—

Benign neoplasm: Rectum

0.00

0.21

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.21

0.0

1.0

—

Cholecystitis

0.00

0.21

0.0

1.0

—

Radiculopathy

0.00

0.21

0.0

1.0

—

Adjustment and management of implanted device

0.00

0.21

0.0

1.0

—

Disorders of speech understanding and production

0.00

0.21

0.0

1.0

—

Disorders of adult personality and behaviour

1.16

0.21

1.0

—

Hypothyroidism, levothyroxine purchases

1.28

0.21

1.0

—

Hypothyroidism and >3 levothyroxin purchases

1.28

0.21

1.0

—

Allergic urticaria

0.00

0.21

0.0

1.0

—

Ankylosing spondylitis, ICD10

0.00

0.21

0.0

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Disorders of continuity of bone

0.00

0.21

0.0

1.0

—

Ankylosing spondylitis

0.00

0.21

0.0

1.0

—

Glomerulonephritis

0.00

0.21

0.0

1.0

—

Other local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Lichen planus

0.00

0.21

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

0.21

0.0

1.0

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.21

0.0

1.0

—

Specific development disorders of scholastic skills

0.00

0.20

0.0

1.0

—

Hypothyroidism (congenital or acquired)

1.23

0.20

1.0

—

Alzheimer disease

0.00

0.20

0.0

1.0

—

Impacted maxillary molar

0.00

0.20

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

0.20

0.0

1.0

—

Twin gestation

0.00

0.20

0.0

1.0

—

Multiple gestation

0.00

0.20

0.0

1.0

—

Abnormal involuntary movements

0.00

0.20

0.0

1.0

—

Sarcoidosis

0.00

0.20

0.0

1.0

—

Pregnancy, childbirth and the puerperium

1.21

0.20

1.0

—

Hypo-osmolality and hyponatraemia

0.00

0.20

0.0

1.0

—

Maternal care for other known or suspected fetal problems

1.20

0.20

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

1.23

0.20

1.0

—

Dental caries 3 and operation codes, only avohilmo

1.16

0.19

1.0

—

Disorders of gallbladder, biliary tract and pancreas

0.82

0.19

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.13

0.18

1.0

—

Delivery, wide proxy

1.20

0.18

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.21

0.18

1.0

—

Other abnormal products of conception

1.14

0.17

1.0

—

Disorders of lens

0.73

0.17

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.12

0.17

1.0

—

1.12

0.17

1.0

—

Ischemic heart diseases

1.19

0.17

1.0

—

Intracranial trauma

1.22

0.17

1.0

—

Contact with and exposure to communicable diseases

0.73

0.17

1.0

—

Used for control exclusion in common control thyroid runs

1.15

0.16

1.0

—

Conductive and sensorineural hearing loss

1.15

0.16

1.0

—

Reimbursement for rheumatic diseases

1.17

0.16

1.0

—

Insulin medication

1.16

0.16

1.0

—

Hypertensive diseases (excluding secondary)

0.74

0.16

1.0

—

Spontaneous abortion

1.21

0.15

1.0

—

Persons with potential health hazards related to communicable diseases

0.79

0.15

1.0

—

Artificial joint operation, meniscal resection

1.21

0.15

1.0

—

Type 2 diabetes

1.16

0.15

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.15

0.13

1.0

—

Renal tubulo-interstitial diseases

1.16

0.13

1.0

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

0.87

0.11

1.0

—

Malignant neoplasm, wide definition for exclusion

0.87

0.11

1.0

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

0.87

0.11

1.0

—

Symptoms and signs involving the urinary system

1.17

0.11

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

0.87

0.10

1.0

—

Open wound of wrist and hand

1.10

0.09

1.0

—

Labour and delivery complicated by fetal stress [distress]

1.08

0.09

1.0

—

Erysipelas

1.09

0.09

1.0

—

STROKE

1.12

0.09

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.09

0.08

1.0

—

Procreative management

1.03

0.08

1.0

—

Cerebrovascular diseases

0.78

0.08

1.0

—

Osteopathies and chondropathies

0.80

0.08

1.0

—

Substance abuse

0.78

0.08

1.0

—

Fracture of lower leg, including ankle

1.09

0.08

1.0

—

Cholecystectomy

0.80

0.07

1.0

—

Diabetes, varying definitions

0.91

0.07

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.10

0.07

1.0

—

Polyarthropathies

1.07

0.07

1.0

—

Acute appendicitis, no complications

0.86

0.07

1.0

—

Leiomyoma of uterus

0.87

0.07

1.0

—

Other diseases of urinary system

1.09

0.07

1.0

—

Parodontitis and operation codes

0.84

0.06

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.90

0.06

1.0

—

Cardiovascular diseases

0.91

0.06

1.0

—

Other (not insulin) diabetes medications

1.10

0.05

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.09

0.03

1.0

—

Cystitis

0.93

0.03

1.0

—

Type 2 diabetes, definitions combined

0.92

0.03

1.0

—

Type 2 diabetes, strict (exclude DM1)

0.92

0.03

1.0

—

Antihypertensive medication - note that there are other indications

1.07

0.03

1.0

—

Diabetes mellitus

1.06

0.03

1.0

—

Any reimbursement code in KELA

1.07

0.02

1.0

—

Hypertension, essential

1.08

0.01

1.0

—

Hypertension

0.94

0.00

1.0

—

Hypertensive diseases

0.94

0.00

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

0.95

0.00

1.0

—

Malignant neoplasm

1.02

0.00

1.0

—

Neoplasms

0.98

0.00

1.0

—

Autoimmune diseases excluding thyroid diseases

0.99

0.00

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.01

0.00

1.0

—

Diseases of appendix

0.98

0.00

1.0

—

Diabetes medication

1.00

0.00

1.0

—

Injuries to the head

109

1.02

0.00

1.0

—

Any event in cancer register

0.99

0.00

1.0

—

Other bacterial diseases

1.01

0.00

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.98

0.00

1.0

—

Biguanides

0.95

0.00

1.0

—

Appendicitis, broad definition

0.99

0.00

1.0

—

Statin medication

1.04

0.00

1.0

—

Injuries to the elbow and forearm

1.00

0.00

1.0

—

Other viral hepatitis

0.00

0.0

1.0

—

Other diseases of oesophagus

0.00

0.0

1.0

—

Aortic aneurysm

0.00

0.0

1.0

—

Anankastic personality disorder

0.00

0.0

1.0

—

Other maltreatment syndromes

0.00

0.0

1.0

—

Vestibular neuronitis

0.00

0.0

1.0

—

Smoking dependency

0.00

0.0

1.0

—

Substance abuse, excluding more controls

0.91

0.00

1.0

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.0

1.0

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.0

—

Diabetic nephropathy

0.00

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

0.0

1.0

—

Benign neoplasm of meninges

0.00

0.0

1.0

—

Extracorporeal dialysis

0.00

0.0

1.0

—

Contraceptive management

1.00

0.00

1.0

—

Care involving dialysis

0.00

0.0

1.0

—

Event of undetermined intent

0.00

0.0

1.0

—

Fracture of forearm

0.95

0.00

1.0

—

Ptosis of eyelid

0.00

0.0

1.0

—

Pregnancy hypertension

0.97

0.00

1.0

—

Chronic suppurative otitis media

0.00

0.0

1.0

—

Hypertrophic scar

0.00

0.0

1.0

—

Other noninflammatory disorders of cervix uteri

0.00

0.0

1.0

—

Hypertrophic disorders of skin

0.00

0.0

1.0

—

Mixed disorders of conduct and emotions

0.00

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.0

1.0

—

Lung diseases due to external agents

0.00

0.0

1.0

—

False labour

0.99

0.00

1.0

—

Retinal vascular occlusion

0.00

0.0

1.0

—

Stenosis and insufficiency of lacrimal passages

0.00

0.0

1.0

—

Other sleep disorders

0.00

0.0

1.0

—

Optic neuritis

0.00

0.0

1.0

—

Other peripheral vertigo

0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

0.0

1.0

—

Malignant neoplasm of colon

0.00

0.0

1.0

—

AV-block

0.00

0.0

1.0

—

Amputation

0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

0.0

1.0

—

Synovial cyst of popliteal space [Baker]

0.00

0.0

1.0

—

Sacroiliitis, not elsewhere classified

0.00

0.0

1.0

—

Allergic colitis

0.00

0.0

1.0

—

Dissociative [conversion] disorders

0.00

0.0

1.0

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

0.0

1.0

—

Behavioural disorders, excluding more controls

0.00

0.0

1.0

—

Persistent delusional disorders

0.00

0.0

1.0

—

Visual impairment including blindness (binocular or monocular)

0.00

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

0.0

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

1.0

—

Benign neoplasm: Parotid gland

0.00

0.0

1.0

—

Use of antiglaucoma preparations and miotics

0.00

0.0

1.0

—

Oral leukoplakia and related diseases, including avohilmo

0.00

0.0

1.0

—

Special screening examination for other diseases and disorders

0.00

0.0

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.01

0.00

1.0

—

Follow-up care involving plastic surgery

0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

0.0

1.0

—

Ankylosing spondylitis, strict definition

0.00

0.0

1.0

—

Scabies

0.00

0.0

1.0

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

0.93

0.00

1.0

—

Hyperkinetic disorders (excl. ADHD)

0.00

0.0

1.0

—

Other assisted single delivery

0.00

0.0

1.0

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

0.0

1.0

—

Fall on and from ladder

0.00

0.0

1.0

—

Contact with heat and hot substances

0.00

0.0

1.0

—

Malignant neoplasm of ovary

0.00

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.0

1.0

—

Lymphoid leukaemia

0.00

0.0

1.0

—

Malignant neoplasm of bronchus and lung

0.00

0.0

1.0

—

Injury of unspecified body region

0.00

0.0

1.0

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Pediculosis, acariasis and other infestations

0.00

0.0

1.0

—

1.00

0.00

1.0

—

Nonischemic cardiomyopathy

0.00

0.0

1.0

—

Injury of other and unspecified intrathoracic organs

0.00

0.0

1.0

—

Early complications of trauma

0.00

0.0

1.0

—

Conduct disorder

0.00

0.0

1.0

—

Drug-induced neutropenia

0.00

0.0

1.0

—

Focal brain injury

0.00

0.0

1.0

—

Gingival hyperplasia

0.00

0.0

1.0

—

Melanocytic naevi of lower limb, including hip

0.00

0.0

1.0

—

Sequelae of injuries of head

0.00

0.0

1.0

—

Disorders of other endocrine glands

0.92

0.00

1.0

—

Rare circulating lymphoid malignancy

0.00

0.0

1.0

—

Tongue abnormality

0.00

0.0

1.0

—

Abscess of Bartholin gland

0.00

0.0

1.0

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Other diseases of jaws

0.00

0.0

1.0

—

Other/unspecified reactive arthropathies

0.00

0.0

1.0

—

Abnormal weight loss

0.00

0.0

1.0

—

Heartburn

0.00

0.0

1.0

—

Ulcerative enterocolitis

0.00

0.0

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.96

0.00

1.0

—

Somnolence, stupor and coma

0.00

0.0

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.94

0.00

1.0

—

Faecal incontinence

0.00

0.0

1.0

—

Intermittent heterotropia

0.00

0.0

1.0

—

Congenital deformities of hip

0.00

0.0

1.0

—

Peripheral arterial reconstruction

0.00

0.0

1.0

—

Other disorders of urethra and urinary system

0.92

0.00

1.0

—

Other disorders originating in the perinatal period

0.00

0.0

1.0

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

0.93

0.00

1.0

—

Type 2 diabetes, wide definition

0.91

0.00

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

0.0

1.0

—

Other diseases of arteries and capillaries

0.00

0.0

1.0

—

Placental disorders

0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

0.0

1.0

—

Infections with a predominantly sexual mode of transmission

0.93

0.00

1.0

—

Intracranial injury

0.94

0.00

1.0

—

Other obstetric trauma

0.00

0.0

1.0

—

Non-small cell lung cancer

0.00

0.0

1.0

—

Gout, strict definition

0.00

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

0.0

1.0

—

Use of donepezil

0.00

0.0

1.0

—

!Aliquae complicationes praecoces traumatis

0.00

0.0

1.0

—

Other and unspecified disorders of psychological development

0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

0.0

1.0

—

Cleft lip, lip and palate or palate

0.00

0.0

1.0

—

Other disorders of cornea

0.00

0.0

1.0

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

0.0

1.0

—

Osteomyelitis

0.00

0.0

1.0

—

Venous complications and haemorrhoids in pregnancy

0.00

0.0

1.0

—

Gout, unspecified

0.00

0.0

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.0

1.0

—

Diverticular disease of intestine

1.00

0.00

1.0

—

Inflammatory disease of cervix uteri

0.00

0.0

1.0

—

Other inflammation of vagina/vulva

0.00

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

0.0

1.0

—

Cyst of Bartholin Gland

0.00

0.0

1.0

—

Scar conditions and fibrosis of skin

0.00

0.0

1.0

—

Other disorders of pigmentation

0.00

0.0

1.0

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

0.0

1.0

—

Enterocolitis due to Clostridium difficile

0.00

0.0

1.0

—

Lung cancer and mesothelioma

0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.0

—

Behavioural disorders

0.00

0.0

1.0

—

Intracerebral haemorrhage

0.00

0.0

1.0

—

Cholelithiasis

0.96

0.00

1.0

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

0.0

1.0

—

Gout

0.00

0.0

1.0

—

Diseases of tongue

0.00

0.0

1.0

—

Other inflammatory liver diseases

0.00

0.0

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

1.0

—

Chronic periodontitis, including avohilmo

0.91

0.00

1.0

—

Parodontitis

0.91

0.00

1.0

—

Exclusion endpoint for supernumerary teeth

0.00

0.0

1.0

—

Viral hepatitis, IBD co-morbidity

0.00

0.0

1.0

—

Thoracic aortic aneurysm

0.00

0.0

1.0

—

Atrial septal defect

0.00

0.0

1.0

—

Benign neoplasm of middle ear and respiratory system

0.00

0.0

1.0

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

Foreign body in alimentary tract

0.00

0.0

1.0

—

Other diseases of biliary tract

0.00

0.0

1.0

—

Cholangitis (primary sclerosing, PSC)

0.00

0.0

1.0

—

Heart failure, not strict

0.86

0.00

1.0

—

Convergent concomitant strabismus

0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

0.0

1.0

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Ascites

0.00

0.0

1.0

—

Hypotension

0.00

0.0

1.0

—

Benign neoplasm: Rectum

0.00

0.0

1.0

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

0.0

1.0

—

Chronic suppurative otitis media, including avohilmo

0.00

0.0

1.0

—

Myocardial infarction, unclassifiable

0.00

0.0

1.0

—

Other and unspecified myopathies

0.00

0.0

1.0

—

Other and unspecified vascular occlusions

0.00

0.0

1.0

—

Retinal vascular disorders

0.00

0.0

1.0

—

Other specified/unspecified hearing loss

0.00

0.0

1.0

—

Other functional intestinal disorders

0.92

0.00

1.0

—

Chronic viral hepatitis

0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

0.0

1.0

—

Mental and behavioural disorders due to opioids

0.00

0.0

1.0

—

Mental and behavioural disorders due to psychoactive substance use

0.94

0.00

1.0

—

Disorders in reading

0.00

0.0

1.0

—

Inguinal or femoral hernia, bilateral

0.00

0.0

1.0

—

Diabetic nephropathy, excluding more controls

0.00

0.0

1.0

—

Other noninflammatory disorders of vagina

0.00

0.0

1.0

—

Other CVD (FINNGEN)

0.00

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

0.0

1.0

—

Arthrosis

0.92

0.00

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.0

—

Other disorders of nervous system

0.00

0.0

1.0

—

Other demyelinating diseases of the central nervous system

0.00

0.0

1.0

—

Respiratory distress of newborn

0.00

0.0

1.0

—

Cluster headache, wide,, including avohilmo

0.00

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

0.0

1.0

—

Exclusion endpoint for clefts

0.00

0.0

1.0

—

Noninfective enteritis and colitis

0.89

0.00

1.0

—

Thrombocytopenia, unspecified

0.00

0.0

1.0

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.0

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

0.0

1.0

—

Unknown and unspecified causes of morbidity

0.00

0.0

1.0

—

Alcohol use disorder, Swedish definition

0.95

0.00

1.0

—

Unspecified abortion

0.00

0.0

1.0

—

Cholelithiasis, broad definition with cholecystitis

0.92

0.00

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

0.0

1.0

—

Lymphoid leukaemia

0.00

0.0

1.0

—

Acute appendicitis

0.94

0.00

1.0

—

Myocarditis

0.00

0.0

1.0

—

Mild mental retardation

0.00

0.0

1.0

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.0

—

Neuromuscular dysfunction of bladder

0.00

0.0

1.0

—

Papillary adenocarcinoma of thyroid gland

0.00

0.0

1.0

—

Acute peritonitis

0.00

0.0

1.0

—

Other and unspecified mental retardation

0.00

0.0

1.0

—

Benign neoplasm: Parotid gland

0.00

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

0.0

1.0

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

0.0

1.0

—

COPD-related respiratory insufficiency

0.00

0.0

1.0

—

Pyogenic arthritis

0.00

0.0

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

0.0

1.0

—

Invasive ventilation

0.00

0.0

1.0

—

Undescended testicle

0.00

0.0

1.0

—

Conotruncal defects

0.00

0.0

1.0

—

Congenital malformations of the nervous system

0.00

0.0

1.0

—

Oesophageal varices

0.00

0.0

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.90

0.00

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.93

0.00

1.0

—

Benign neoplasm: Cerebral meninges

0.00

0.0

1.0

—

Subarachnoid haemorrhage

0.00

0.0

1.0

—

Parodontitis or operation codes

0.91

0.00

1.0

—

Alzheimer’s disease, wide definition

0.00

0.0

1.0

—

Inguinal hernia, bilateral

0.00

0.0

1.0

—

Other obstructed labour

0.00

0.0

1.0

—

Other disorders of breast and lactation associated with childbirth

0.00

0.0

1.0

—

Other osteochondropathies

0.00

0.0

1.0

—

Senile cataract

0.89

0.00

1.0

—

Opening and dilatation of root channel of tooth

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

1.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

-0.00

0.0

1.0

—

Pneumothorax

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Smooth Alder IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS